4//SEC Filing
Link Charles J. Jr. 4
Accession 0001126234-18-000041
CIK 0001126234other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:52 PM ET
Size
6.9 KB
Accession
0001126234-18-000041
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
Link Charles J. Jr.
DirectorChairman of the Board & CEO
Transactions
- Award
Stock Option (Right to Buy)
2018-03-09+310,000→ 310,000 totalExercise: $7.85→ Common Stock (310,000 underlying)
Footnotes (3)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan") on March 9, 2018 (the "Date of Grant"). 50% of the option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2018, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the Date of Grant.
- [F2]The remaining 50% of the stock options vest and become exercisable as follows: (a) 25% of such shares shall vest as to 8.33%, 8.33% and 8.34% on the 1st day of the month following an increase of closing share price on Nasdaq Stock Market by at least 33.33%, 66.66% and 100%, respectively, above the exercise price of the options when measured over 30 consecutive calendar days, provided such increase occurs within four years of the Date of Grant, otherwise such options shall be cancelled; (b) 12.50% of such shares shall vest on the 1st day of the month following the hiring of a new senior operations executive to oversee the Company's chemistry and manufacturing control ("CMC") activities and clinical trials; and (c) the remaining 12.50% of such shares shall vest on the 1st day of the month following completion of a CMC formulation for indoximod for adult patients and completion of a CMC plan for a pediatric formulation of indoximod, the completion of each to be determined by the Board.
- [F3]Unless otherwise disclosed, the option expires ten years after the date of grant.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeother
Related Parties
1- filerCIK 0001512113
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:52 PM ET
- Size
- 6.9 KB